Nicolas Villain

Citado por

	Total	Desde 2020
Citas	5949	4170
Índice h	36	33
Índice i10	58	56

1100

550

275

825

2009201020112012201320142015201620172018201920202021202220232024202521 44 75 132 152 201 173 184 206 217 337 369 677 848 992 1100 148

Acceso público

Ver todo

54 artículos

2 artículos

disponibles

no disponibles

Basado en requisitos de financiación

Coautores

Gael ChételatResearcher (Inserm, French institute for biomedical research)Dirección de correo verificada de cyceron.fr
bruno duboisDirección de correo verificada de aphp.fr
Marie-Odile HabertNuclear Medicine / Biophysics, Pitié-Salpêtrière Hospital, Sorbonne Universités, UPMC Laboratoire dDirección de correo verificada de upmc.fr
Stéphane EpelbaumInternational Leader Neuroscience - Eli LillyDirección de correo verificada de lilly.com
Audrey PerrotinInserm U1077Dirección de correo verificada de cyceron.fr
Harald Hampel, MD, PhD, MA, MScChief Medical Officer, Senior Vice President, Eisai Inc.Dirección de correo verificada de eisai.com
Andrea Vergallo, MDSorbonne UniversityDirección de correo verificada de kcl.ac.uk
Simone Listai+HeALTH Strategic Research Group, Miguel de Cervantes European UniversityDirección de correo verificada de uemc.es
Jeffrey CummingsCleveland Clinic Lou Ruvo Center for Brain HealthDirección de correo verificada de ccf.org
Kaj BlennowProfDirección de correo verificada de neuro.gu.se
Colin Louis MastersThe University of MelbourneDirección de correo verificada de florey.edu.au
Ralph N. MartinsEdith Cowan UniversityDirección de correo verificada de ecu.edu.au
Kathryn EllisUniversity of MelbourneDirección de correo verificada de unimelb.edu.au
jean-claude baronprofessor of stroke medicine, university of cambridgeDirección de correo verificada de inserm.fr
Gareth JonesThe University of MelbourneDirección de correo verificada de petermac.org
Vincent PlancheProfessor of Neurology, Bordeaux UniversityDirección de correo verificada de u-bordeaux.fr
Alexandre Bejanin (ORCID:0000-0002...Institut de Recerca Sant Pau - Centre CERCA, Barcelona, Spain.Dirección de correo verificada de santpau.cat
Giovanni B FrisoniDirector, Centre de la mémoireDirección de correo verificada de unige.ch
Stephane LehericyProfessor in Neuroradiology, Sorbonne-UniversitéDirección de correo verificada de sorbonne-universite.fr
Marwan SabbaghProfessor of NeurologyDirección de correo verificada de dignityhealth.org

Seguir

Nicolas Villain

Sorbonne University - Assistance Publique Hôpitaux de Paris - Pitié-Salpêtrière Hospital

Dirección de correo verificada de cyceron.fr - Página principal

Neuroimaging biomarkers Alzheimer's disease MRI PET


Título Ordenar por citas Ordenar por año Ordenar por título	Citado por Citado por	Año
Clinical diagnosis of Alzheimer's disease: recommendations of the International Working Group B Dubois, N Villain, GB Frisoni, GD Rabinovici, M Sabbagh, S Cappa, ... The Lancet Neurology 20 (6), 484-496, 2021	842	2021
Relationships between hippocampal atrophy, white matter disruption, and gray matter hypometabolism in Alzheimer's disease N Villain, B Desgranges, F Viader, V De La Sayette, F Mézenge, ... Journal of Neuroscience 28 (24), 6174-6181, 2008	465	2008
Amyloid imaging in cognitively normal individuals, at-risk populations and preclinical Alzheimer's disease G Chételat, R La Joie, N Villain, A Perrotin, V de La Sayette, F Eustache, ... NeuroImage: Clinical, 2013	411	2013
Regional dynamics of amyloid-β deposition in healthy elderly, mild cognitive impairment and Alzheimer’s disease: a voxelwise PiB–PET longitudinal study N Villain, G Chételat, B Grassiot, P Bourgeat, G Jones, KA Ellis, D Ames, ... Brain 135 (7), 2126-2139, 2012	301	2012
Sequential relationships between grey matter and white matter atrophy and brain metabolic abnormalities in early Alzheimer's disease N Villain, M Fouquet, JC Baron, F Mézenge, B Landeau, V de La Sayette, ... Brain 133 (11), 3301-3314, 2010	255	2010
Accelerated cortical atrophy in cognitively normal elderly with high β-amyloid deposition G Chételat, VL Villemagne, N Villain, G Jones, KA Ellis, D Ames, ... Neurology 78 (7), 477-484, 2012	208	2012
COVID‐19‐related encephalopathy: a case series with brain FDG‐positron‐emission tomography/computed tomography findings C Delorme, O Paccoud, A Kas, A Hesters, S Bombois, P Shambrook, ... European journal of neurology 27 (12), 2651-2657, 2020	195	2020
Differential effect of age on hippocampal subfields assessed using a new high-resolution 3T MR sequence R La Joie, M Fouquet, F Mézenge, B Landeau, N Villain, K Mevel, ... Neuroimage 53 (2), 506-514, 2010	186	2010
Retrospective observational study of brain MRI findings in patients with acute SARS-CoV-2 infection and neurologic manifestations L Chougar, N Shor, N Weiss, D Galanaud, D Leclercq, B Mathon, ... Radiology 297 (3), E313-E323, 2020	183*	2020
The cerebral network of COVID-19-related encephalopathy: a longitudinal voxel-based 18F-FDG-PET study A Kas, M Soret, N Pyatigoskaya, MO Habert, A Hesters, L Le Guennec, ... European journal of nuclear medicine and molecular imaging 48 (8), 2543-2557, 2021	165	2021
Plasma amyloid β 40/42 ratio predicts cerebral amyloidosis in cognitively normal individuals at risk for Alzheimer's disease A Vergallo, L Mégret, S Lista, E Cavedo, H Zetterberg, K Blennow, ... Alzheimer's & Dementia 15 (6), 764-775, 2019	158	2019
Revolution of Alzheimer precision neurology. Passageway of systems biology and neurophysiology H Hampel, N Toschi, C Babiloni, F Baldacci, KL Black, ALW Bokde, ... Journal of Alzheimer's Disease 64 (s1), S47-S105, 2018	153	2018
Age effect on the default mode network, inner thoughts, and cognitive abilities K Mevel, B Landeau, M Fouquet, R La Joie, N Villain, F Mézenge, ... Neurobiology of aging 34 (4), 1292-1301, 2013	149	2013
Alzheimer's disease including focal presentations N Villain, B Dubois Seminars in neurology 39 (02), 213-226, 2019	125	2019
The spatiotemporal changes in dopamine, neuromelanin and iron characterizing Parkinson’s disease E Biondetti, MD Santin, R Valabrègue, G Mangone, R Gaurav, ... Brain 144 (10), 3114-3125, 2021	118	2021
Functional brain imaging of trigeminal neuralgia X Moisset, N Villain, D Ducreux, A Serrie, G Cunin, D Valade, B Calvino, ... European Journal of Pain 15 (2), 124-131, 2011	118	2011
Omics sciences for systems biology in Alzheimer’s disease: State-of-the-art of the evidence H Hampel, R Nisticò, NT Seyfried, AI Levey, E Modeste, P Lemercier, ... Ageing Research Reviews 69, 101346, 2021	117	2021
Dementia prevention in memory clinics: recommendations from the European task force for brain health services GB Frisoni, D Altomare, F Ribaldi, N Villain, C Brayne, N Mukadam, ... The Lancet Regional Health–Europe 26, 2023	113	2023
Precision pharmacology for Alzheimer’s disease H Hampel, A Vergallo, LF Aguilar, N Benda, K Broich, AC Cuello, ... Pharmacological research 130, 331-365, 2018	104	2018
The Alzheimer precision medicine initiative H Hampel, A Vergallo, G Perry, S Lista, ... Journal of Alzheimer's Disease 68 (1), 1-24, 2019	102	2019

El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.

Artículos 1–20

Citas por año

Citas duplicadas

Citas combinadas

Añadir coautoresCoautores

Seguir

Citado por

Coautores